252 related articles for article (PubMed ID: 29908691)
21. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer.
Landers A; Muircroft W; Brown H
BMJ Support Palliat Care; 2016 Mar; 6(1):75-9. PubMed ID: 25164613
[TBL] [Abstract][Full Text] [Related]
22. Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study.
Landers A; Brown H; Al Ruheili J; Russell K; McKenzie C; Agar MR; Yenson VM; Clarke K; Windsor J
Support Care Cancer; 2024 Jun; 32(6):402. PubMed ID: 38831230
[TBL] [Abstract][Full Text] [Related]
23. Importance of Pancreatic Enzyme Replacement Therapy after Surgery of Cancer of the Esophagus or the Esophagogastric Junction.
Kiefer T; Krahl D; Osthoff K; Thuss-Patience P; Bunse J; Adam U; Jansen MH; Ott R; Pfitzmann R; Pross M; Kohlmann T; Daeschlein G; Buhlert H; Völler H; Hirt C
Nutr Cancer; 2018 Jan; 70(1):69-72. PubMed ID: 28945459
[TBL] [Abstract][Full Text] [Related]
24. COMPARING THE ENZYME REPLACEMENT THERAPY COST IN POST PANCREATECTOMY PATIENTS DUE TO PANCREATIC TUMOR AND CHRONIC PANCREATITIS.
Fragoso AV; Pedroso MR; Herman P; Montagnini AL
Arq Gastroenterol; 2016; 53(2):94-7. PubMed ID: 27305415
[TBL] [Abstract][Full Text] [Related]
25. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
26. Management of pancreatic exocrine insufficiency.
Dominguez-Muñoz JE
Curr Opin Gastroenterol; 2019 Sep; 35(5):455-459. PubMed ID: 31219829
[TBL] [Abstract][Full Text] [Related]
27. Exocrine pancreatic insufficiency and fat malabsorption related to pancreatectomy and other gastrointestinal surgery: A narrative review.
Morris-Stiff G
Nutr Clin Pract; 2024 Apr; 39 Suppl 1():S35-S45. PubMed ID: 38429966
[TBL] [Abstract][Full Text] [Related]
28. Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.
Ammar K; Leeds JS; Ratnayake CB; Sen G; French JJ; Nayar M; Oppong KW; Loveday BP; Pandanaboyana S
Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):941-948. PubMed ID: 33522321
[No Abstract] [Full Text] [Related]
29. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
[TBL] [Abstract][Full Text] [Related]
30. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
[TBL] [Abstract][Full Text] [Related]
31. Transient Exocrine Pancreatic Insufficiency: First Report of an Unrecognized Complication of Cytoreductive Surgery and HIPEC.
Naffouje SA; Salti GI
Anticancer Res; 2018 Apr; 38(4):2353-2358. PubMed ID: 29599360
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Pancreatic Enzyme Replacement Therapy on Patients With Advanced Pancreatic Adenocarcinoma: A Systematic Review and Narrative Synthesis.
Landers A; Donaldson F; Brown H; McKenzie C; Pendharkar S
Pancreas; 2022 May; 51(5):405-414. PubMed ID: 35973015
[TBL] [Abstract][Full Text] [Related]
33. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.
Boon M; Calvo-Lerma J; Claes I; Havermans T; Asseiceira I; Bulfamante A; Garriga M; Masip E; van Schijndel BAM; Fornes V; Barreto C; Colombo C; Crespo P; Vicente S; Janssens H; Hulst J; Witters P; Nobili R; Pereira L; Ruperto M; Van der Wiel E; Mainz JG; De Boeck K; Ribes-Koninckx C
J Cyst Fibros; 2020 Jul; 19(4):562-568. PubMed ID: 32335023
[TBL] [Abstract][Full Text] [Related]
34. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.
Lindkvist B; Phillips ME; Domínguez-Muñoz JE
Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic exocrine insufficiency following pancreatic resection.
Phillips ME
Pancreatology; 2015; 15(5):449-455. PubMed ID: 26145836
[TBL] [Abstract][Full Text] [Related]
36. Survival benefit of pancreatic enzyme replacement therapy in patients undergoing treatment of pancreatic neuroendocrine tumours.
Thompson O; Hall L; Roberts K; Bradley E; Powell-Brett S; Pande R; Shah T
HPB (Oxford); 2022 Nov; 24(11):1921-1929. PubMed ID: 35811220
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic enzyme replacement therapy in chronic pancreatitis.
Sikkens EC; Cahen DL; Kuipers EJ; Bruno MJ
Best Pract Res Clin Gastroenterol; 2010 Jun; 24(3):337-47. PubMed ID: 20510833
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and Risk Factors for Pancreatic Insufficiency After Partial Pancreatectomy.
Thomas AS; Huang Y; Kwon W; Schrope BA; Sugahara K; Chabot JA; Wright JD; Kluger MD
J Gastrointest Surg; 2022 Jul; 26(7):1425-1435. PubMed ID: 35318597
[TBL] [Abstract][Full Text] [Related]
39. Practice and perspectives of Australian dietitians in management of patients on pancreatic enzyme replacement therapy.
Delaney C; Vo R; Beck E
Nutr Diet; 2021 Apr; 78(2):165-173. PubMed ID: 32222032
[TBL] [Abstract][Full Text] [Related]
40. The daily practice of pancreatic enzyme replacement therapy after pancreatic surgery: a northern European survey: enzyme replacement after surgery.
Sikkens EC; Cahen DL; van Eijck C; Kuipers EJ; Bruno MJ
J Gastrointest Surg; 2012 Aug; 16(8):1487-92. PubMed ID: 22711213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
